Dr. Lal PathLabs Ltd reported a revenue of Rs 670 Cr for Q1 FY26, up by 11.3%, with a PAT increase of 24.3%, and declared an interim dividend of Rs 6 per share. This announcement is based on their un-audited financial results for the quarter ending June 30, 2025, released on July 31, 2025.